Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models.

Saved in:
Bibliographic Details
Title: Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models.
Authors: Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Yang SD; Department of Cyber Security & AI Technology, Kyung Hee Cyber University, Seoul, Republic of Korea., Lim S; Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea., Heo SG; Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea., Daniel S; Translational Science, Oncology R&D, AstraZeneca, Boston, MA, USA., Markovets A; Translational Science, Oncology R&D, AstraZeneca, Boston, MA, USA., Minoo R; Translational Science, Oncology R&D, AstraZeneca, Boston, MA, USA., Pyo KH; Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea., Yun MR; Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea., Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, 03722, Republic of KoreaYonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Feb 26; Vol. 14, pp. 17588359221079125. Date of Electronic Publication: 2022 Feb 26 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1758-8340
DOI:10.1177/17588359221079125